Guillain-Barré syndrome during childhood: particular clinical and electrophysiological features

David Devos1, Armelle Magot, Julie Perrier-Boeswillwald

  • 1Laboratoire d'Explorations Fonctionnelles, Centre de Référence Maladies Neuromusculaires Nantes-Angers, Hôtel-Dieu, F-44093 Nantes Cedex, France.

Muscle & Nerve
|July 2, 2013
PubMed

Insights

Guillain-Barré syndrome (GBS) in children often presents with gait disturbance and leg pain. Most pediatric GBS cases show electrophysiological abnormalities and have a good prognosis, often with complete recovery.

Area of Science:

  • Pediatric Neurology
  • Clinical Electrophysiology
  • Autoimmune Disorders

Background:

  • Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting the peripheral nervous system.
  • Specific clinical and prognostic features of GBS in pediatric populations require detailed characterization.

Purpose of the Study:

  • To delineate the specific clinical, electrophysiological, and prognostic characteristics of Guillain-Barré syndrome in children.
  • To identify key features distinguishing pediatric GBS from adult cases.

Main Methods:

  • Retrospective review of 19 pediatric GBS cases diagnosed between 2000 and 2011.
  • Analysis of clinical presentation, laboratory findings, electrophysiological data, and long-term prognosis.

Main Results:

  • Gait disturbance and leg pain were the most common initial symptoms.
  • Electrophysiological studies frequently revealed decreased distal Compound Muscle Action Potential (CMAP) amplitude (89%) and acute inflammatory demyelinating polyneuropathy (95%).
  • Most children received intravenous immunoglobulin, and 17 out of 19 patients achieved complete recovery within a year.

Conclusions:

  • Pediatric Guillain-Barré syndrome is characterized by gait disorders, leg pain, and a high incidence of distal conduction block.
  • The condition in children typically demonstrates significant electrophysiological abnormalities and a favorable prognosis with a high rate of complete recovery.
Abstract

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...